about
sameAs
Spread of artemisinin resistance in Plasmodium falciparum malariaA single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira speciesGenetic diversity and microevolution of Burkholderia pseudomallei in the environmentCommon NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association studyComplete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistanceRapid immunofluorescence microscopy for diagnosis of melioidosisRole and significance of quantitative urine cultures in diagnosis of melioidosis.Comparison of Ashdown's medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei.Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapseTransmission-blocking activities of quinine, primaquine, and artesunateDetection of Burkholderia pseudomallei in soil within the Lao People's Democratic RepublicLack of association between Toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureusPlasmodium falciparum histones induce endothelial proinflammatory response and barrier dysfunctionEmergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyTrimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trialPrevalence of melioidosis in patients with suspected pulmonary tuberculosis and sputum smear negative for acid-fast bacilli in northeast ThailandIncreasing incidence of human melioidosis in Northeast ThailandLethal malaria: Marchiafava and Bignami were rightEnzyme-linked immunosorbent assay for the diagnosis of melioidosis: better than we thoughtArtesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialGenotyping of Orientia tsutsugamushi from humans with scrub typhus, LaosDosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosisDoxycycline versus azithromycin for treatment of leptospirosis and scrub typhusBiological relevance of colony morphology and phenotypic switching by Burkholderia pseudomalleiAccuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination testEstimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2Predicted global distribution of Burkholderia pseudomallei and burden of melioidosisComparative efficacy of interventions to promote hand hygiene in hospital: systematic review and network meta-analysisMelioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposesProspective Study To Determine Accuracy of Rapid Serological Assays for Diagnosis of Acute Dengue Virus Infection in LaosGenetic architecture of artemisinin-resistant Plasmodium falciparumCommunity engagement and population coverage in mass anti-malarial administrations: a systematic literature review.Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introductionDevelopment and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urineSurvival of Burkholderia pseudomallei in distilled water for 16 yearsCISH and susceptibility to infectious diseasesFunctional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal diseaseIsolation of a novel Orientia species (O. chuto sp. nov.) from a patient infected in DubaiMelioidosis: insights into the pathogenicity of Burkholderia pseudomalleiOseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza
P50
Q21032481-4044DD91-A801-4059-ACFB-44394CA67E63Q21144487-2EB22923-1FC4-424D-B958-7858244B08CEQ21144556-0CFA929C-0A01-48BB-8E77-04BC947B8F63Q21194911-0F3C077F-002D-4DB6-A584-032FB0F48D61Q22066348-A9D379AD-3371-4CB6-82E8-81E8C3F71121Q24521459-E42407A3-B7D0-421C-8218-19E5436C34F0Q24529961-568A86A3-3F00-4342-93BB-B042C27AF8C3Q24533433-5B017050-1FAB-4C97-A843-DC4CD6543C77Q24535314-6CEDDC4F-7527-4F4C-B217-D747287A9A58Q24548262-D4FF29A8-C0D9-4B46-856D-65A690FA903BQ24556783-E9D4611F-0BF5-4F02-9B0B-EC410656901EQ24562023-8739BF95-14DF-4C1A-B730-7E88F40A9E66Q24597556-DC19A950-C68A-4191-A781-CB4F19C92CA5Q24598695-38865960-0E06-4933-8D48-2DA20B01EE96Q24599933-5934C2C0-971F-47F5-9C80-D2B3E2D50FFBQ24601825-4C8909F6-6B98-43A8-AB6A-A0B481AEF62BQ24605111-D80053A3-C1D3-4071-B2FF-CA45B96A1E58Q24611213-B2975261-CC64-429F-8F97-6C168BDDB372Q24628509-8FF1FF21-1006-4832-B093-C5105CE31091Q24630683-BA804D3E-6620-4E13-8E20-62B0D6397E79Q24644941-384F7105-257D-4CF4-B949-19F93244730DQ24651516-1A2C0C27-23B9-45F6-8C6A-B0672737EFAAQ24673103-A0858DFF-C868-4427-A7E3-762BA19A199DQ24676000-411579CE-F200-4C2B-B903-AE2AB34B6765Q24681846-79CBE7E2-FB01-47DF-A172-A8FD718E2FF4Q24814830-0C2DBD62-8AF9-476A-94D9-B0D668DCA671Q26782032-0FD50506-949A-466D-AB91-39942E20FEBFQ26798293-A01B561A-8443-4267-9DA8-BB3FFDBB98DFQ27305733-9CF761F4-0DBE-4A34-905D-56D5F5D9D8EAQ27484658-545C0ED4-74E0-4CCC-ABBE-C617B6CD49FDQ28030935-A5F013B8-1EAB-4DE4-8628-25DAEFB421FDQ28074520-0CAD7B06-6FE3-4AD7-ABB6-AD041FBDA231Q28125932-EE26A4E6-7241-4FC3-BA8B-8F402BF3069FQ28193601-6F5FF25D-4F2E-4474-AE52-0C988E7B6DBAQ28243361-E9890A51-6D09-405D-85EF-2379D28A76C2Q28282872-94C11848-BE6D-4ED1-BA63-04CFEAB92635Q28294642-7625F70E-BA4E-4C3C-BA33-7181ECA13DC5Q28295006-2FEA69CD-0FCF-4D67-8C26-164E09E17011Q28302368-200525D7-54AD-4582-85EF-0E2ED6CDD2A0Q28473860-06AE1AFC-4880-4BAB-AB6A-62E91CA7FF6D
P50
description
epidemiologist
@en
wetenschapper
@nl
name
Nicholas P Day
@nl
Nicholas P J Day
@en
Nicholas P J Day
@es
type
label
Nicholas P Day
@nl
Nicholas P J Day
@en
Nicholas P J Day
@es
altLabel
N P Day
@en
N P J Day
@en
N. P. Day
@en
N. P. J. Day
@en
Nicholas Day
@en
Nicholas P Day
@en
Nicholas P. Day
@en
Nicholas P. J. Day
@en
prefLabel
Nicholas P Day
@nl
Nicholas P J Day
@en
Nicholas P J Day
@es
P106
P1960
a9XBI-wAAAAJ
P21
P31
P496
0000-0003-2309-1171
P569
2000-01-01T00:00:00Z
P6023
2044620254